550,584 research outputs found

    ANALISIS PENERAPAN ARTIFICIAL INTELLIGENCE DALAM MENDETEKSI FRAUD PADA PROSES AUDIT (Studi Literatur Proses Audit di Asia dan Amerika)

    Get PDF
    This research aims to determine the influence of implementing Artificial Intelligence (AI) in detecting fraud in the audit process in Asia and America. This study uses a literature review method sourced from national and international journals originating from countries in Asia and America. The results obtained from this research indicate that Artificial Intelligence (AI) has a significant impact on the audit process, especially in detecting fraud. In terms of the sophistication priority scale possessed by AI, researchers can rank AI from the most advanced, namely Artificial Neural Network (ANN), Large Language Models (LLM), Complaint Management System (CMS), Behavior and Emotion Analytics Tool (BEAT), to Machine Learning, Big Data, Cloud Computing, and Fuzzy Methods, which are ranked last based on the most advanced AI

    Industry-scale application and evaluation of deep learning for drug target prediction

    Get PDF
    Artificial intelligence (AI) is undergoing a revolution thanks to the breakthroughs of machine learning algorithms in computer vision, speech recognition, natural language processing and generative modelling. Recent works on publicly available pharmaceutical data showed that AI methods are highly promising for Drug Target prediction. However, the quality of public data might be different than that of industry data due to different labs reporting measurements, different measurement techniques, fewer samples and less diverse and specialized assays. As part of a European funded project (ExCAPE), that brought together expertise from pharmaceutical industry, machine learning, and high-performance computing, we investigated how well machine learning models obtained from public data can be transferred to internal pharmaceutical industry data. Our results show that machine learning models trained on public data can indeed maintain their predictive power to a large degree when applied to industry data. Moreover, we observed that deep learning derived machine learning models outperformed comparable models, which were trained by other machine learning algorithms, when applied to internal pharmaceutical company datasets. To our knowledge, this is the first large-scale study evaluating the potential of machine learning and especially deep learning directly at the level of industry-scale settings and moreover investigating the transferability of publicly learned target prediction models towards industrial bioactivity prediction pipelines.Web of Science121art. no. 2
    corecore